3 news items
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
HBIO
16 May 24
announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
HBIO
7 Mar 24
for the fourth quarter and year ended December 31, 2023. Jim Green, Chairman and CEO said, "Our fourth quarter revenue was down a modest
Harvard Bioscience To Showcase Latest Solutions For Preclinical And Organoid Applications At Society Of Toxicology Meeting
HBIO
6 Mar 24
DevelopmentJim Green, Harvard Bioscience Chairman and CEO, said, "We are pleased to offer our CRO, pharma, and biotech customers innovative
- Prev
- 1
- Next